Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1414 participants.

Also called NCT03112980

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,414 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03112980
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03112980. Randomized; no masking; primary purpose treatment. Start 2017-05-10 (actual); primary completion 2028-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality
Acronym
DEDICATE
Condition
Aortic Valve Stenosis
Intervention (Device)
Transcatheter aortic valve implantation
Intervention (Procedure)
Surgical aortic valve replacement
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf (class: other)
Collaborator
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (class: other)
Collaborator
The German Heart Foundation (class: other)

Record details

Record id
cardio:ct-nct03112980
Content hash
9643427c2bca3f4bffd3989d39155d1ff63f0028cb62e13f30942d46fd9ba7a5